Vitrolife appoints Patrik Tolf as new CFO

Patrik Tolf has been appointed new CFO of Vitrolife AB (publ) effective 1 January 2022. Patrik is currently interim CFO at Karolinska University Hospital. Patrik is 51 years old and holds a master's degree in business administration and has previously held senior finance positions within Volvo Car Group and Saab AB (publ).

"We are pleased to welcome Patrik Tolf to Vitrolife and our executive management team and we look forward to benefiting from Patrik's broad operational and strategic experience in the company's continued growth journey," says Thomas Axelsson, CEO.

Patrik Tolf replaces Mikael Engblom who remains CFO until Patrik takes office.

Gothenburg, October 21, 2021
VITROLIFE AB (publ)
Thomas Axelsson, CEO

Queries should be addressed to:
Thomas Axelsson, CEO, tel 46 31 721 80 01
Mikael Engblom, CFO, tel 46 31 721 80 14

The information was submitted for publication, through the agency of the contact person set out above, at 8.30 am CET on October 21, 2021.

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

_________________________________________________________________________________________________________________

Vitrolife is an international medical device Group. Vitrolife develops, produces and markets medical devices for assisted reproduction.

Vitrolife has approximately 400 employees and the company's products are sold in about 110 markets. The company is headquartered in Gothenburg, Sweden, and there are also offices in Australia, Belgium, China, Denmark, France, Germany, Italy, Japan, United Kingdom and USA. The Vitrolife share is listed on NASDAQ Stockholm.

Vitrolife AB (publ), Box 9080, SE-400 92 Göteborg, Sweden. Corporate identity number 556354-3452. Tel: 46 31 721 80 00. Fax: 46 31 721 80 99. E-mail: info@vitrolife.com. Website: www.vitrolife.com/